154 related articles for article (PubMed ID: 2398880)
1. [Sex hormone-binding globulin in breast cancer].
Suminaga Y; Morimoto T; Komaki K; Mori T; Monden Y
Nihon Geka Gakkai Zasshi; 1990 Jul; 91(7):875-82. PubMed ID: 2398880
[TBL] [Abstract][Full Text] [Related]
2. Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue in postmenopausal women.
Hofling M; Löfgren L; von Schoultz E; Carlström K; Söderqvist G
Gynecol Endocrinol; 2008 Jul; 24(7):405-10. PubMed ID: 18645713
[TBL] [Abstract][Full Text] [Related]
3. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
[TBL] [Abstract][Full Text] [Related]
4. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
[TBL] [Abstract][Full Text] [Related]
5. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
[TBL] [Abstract][Full Text] [Related]
6. Plasma sex hormone-binding globulin (SHBG) and obesity in breast cancer patients.
Murayama Y
Cancer Detect Prev; 1983; 6(4-5):425-33. PubMed ID: 6686084
[TBL] [Abstract][Full Text] [Related]
7. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
8. The relationship between endogenous estrogen, sex hormone-binding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study.
Yoshimura N; Kasamatsu T; Sakata K; Hashimoto T; Cooper C
J Bone Miner Metab; 2002; 20(5):303-10. PubMed ID: 12203037
[TBL] [Abstract][Full Text] [Related]
9. [Competitive binding assay with dextran-coated charcoal for measurement of sex hormone-binding globulin in breast cancer].
Suminaga Y; Sonoo H; Morimoto T
Nihon Geka Gakkai Zasshi; 1986 Mar; 87(3):341-9. PubMed ID: 2423861
[TBL] [Abstract][Full Text] [Related]
10. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
[TBL] [Abstract][Full Text] [Related]
11. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
[TBL] [Abstract][Full Text] [Related]
12. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
Celio L; Martinetti A; Ferrari L; Buzzoni R; Mariani L; Miceli R; Seregni E; Procopio G; Cassata A; Bombardieri E; Bajetta E
Anticancer Res; 1999; 19(3B):2261-8. PubMed ID: 10472341
[TBL] [Abstract][Full Text] [Related]
13. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls.
Takatani O; Kosano H; Okumoto T; Akamatsu K; Tamakuma S; Hiraide H
J Natl Cancer Inst; 1987 Dec; 79(6):1199-204. PubMed ID: 3480371
[TBL] [Abstract][Full Text] [Related]
14. Plasma sex steroids and SHBG in patients with breast cancer and their relation to tumor oestrogen-dependency.
Teruel M; Bolufer P; Rodriguez A; Antonio P; Salabert MT
Exp Clin Endocrinol; 1989 Apr; 93(1):37-44. PubMed ID: 2737240
[TBL] [Abstract][Full Text] [Related]
15. Sex hormone-binding globulin and estrogen receptor in breast cancer: technique and preliminary clinical results.
Murayama Y; Sakuma T; Udagawa H; Utsunomiya J; Okamoto R; Asano K
J Clin Endocrinol Metab; 1978 Jun; 46(6):998-1006. PubMed ID: 263661
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability of estradiol as a marker for breast cancer risk assessment.
Jones LA; Ota DM; Jackson GA; Jackson PM; Kemp K; Anderson DE; McCamant SK; Bauman DH
Cancer Res; 1987 Oct; 47(19):5224-9. PubMed ID: 3621208
[TBL] [Abstract][Full Text] [Related]
17. Relationship between sex hormone binding globulin and estrogen receptors in breast cancer.
Plymate SR; Stutz FH; Fariss BL
J Clin Oncol; 1984 Jun; 2(6):652-4. PubMed ID: 6539364
[TBL] [Abstract][Full Text] [Related]
18. Free estradiol and breast cancer risk in postmenopausal women: comparison of measured and calculated values.
Endogenous Hormones and Breast Cancer Collaborative Group
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1457-61. PubMed ID: 14693737
[TBL] [Abstract][Full Text] [Related]
19. [Mechanism and classification of hormone therapy for human breast cancer studied by changes of SHBG binding capacity].
Murayama Y
Gan No Rinsho; 1984 Dec; 30(15):1879-82. PubMed ID: 6543230
[TBL] [Abstract][Full Text] [Related]
20. Changes in sex hormone-binding globulin, insulin, and serum lipids in postmenopausal women on a low-fat, high-fiber diet combined with exercise.
Tymchuk CN; Tessler SB; Barnard RJ
Nutr Cancer; 2000; 38(2):158-62. PubMed ID: 11525592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
